Opexa Pharmaceuticals, Inc. to Present at the Oppenheimer 22nd Annual Healthcare Conference
12/9/2011 6:46:14 AM
More...
|
Opexa Pharmaceuticals, Inc. Executes Strategic Service Agreement with the American Red Cross
5/17/2011 10:29:22 AM
More...
|
Opexa Pharmaceuticals, Inc. to Participate in Panel Discussion on Personalized Medicine for Multiple Sclerosis
4/1/2010 10:41:16 AM
More...
|
Seasoned Clinical Development Expert Joins Opexa Pharmaceuticals, Inc. to Lead Tovaxin(R) Development in Multiple Sclerosis
12/2/2009 9:26:14 AM
More...
|
Opexa Pharmaceuticals, Inc. Regains NASDAQ Compliance Following Stem Cell Agreement
8/10/2009 9:43:02 AM
More...
|
Opexa Pharmaceuticals, Inc. Reports First Quarter 2008 Financial Results and Updates on Tovaxin(R) Phase IIb Study
5/14/2008 8:49:25 AM
More...
|
Opexa Pharmaceuticals, Inc. Presents Tovaxin Phase I/II Data at the American Academy of Neurology 60th Annual Meeting
4/16/2008 9:25:26 AM
More...
|
The Day In Review: Cell Genesys, Inc. (CEGE) Climbs On GVAX Results
4/4/2007 11:00:52 AM
More...
|
PharmaFrontiers Changes Name To Opexa Pharmaceuticals, Inc.
6/19/2006 3:13:15 PM
More...
|
PharmaFrontiers Provides Update, Financial Results
10/19/2005 5:12:42 PM
More...
|
|